行业专家指导战略前进

马丁·弗罗斯特（Martin Frost）已加入Creavo医疗技术，担任董事会主席，负责推动公司的筹款计划，指导其业务扩展策略和诊断技术的商业化。

Using a platform designed around mapping and analysing the magnetic fields of the heart, the company is developing a medical device for use by non-medical staff on patients’ admitted to A&E departments to rule out potentially life-threatening heart problems where appropriate, helping reduce patient anxiety and saving valuable time and resources.

With over 20 years of industry experience, Martin co-founded CMR Surgical in 2014 and as CEO was recognised as ‘UK Disruptor of the year’ in the 2019 Entrepreneur of the Year awards, and ‘Executive of the Year’ at the 2019 MedTech Insight awards. He has also held several C-suite positions including CEO and CFO of Sagentia and he is currently Chair of the Peek Vision Foundation.

马丁接替罗伯特·巴尔（Robert Barr），他自2009年以来就一直与Creavo创始人，本·瓦尔科（Ben Varcoe）教授一起支持这项技术，并通过概念研究证明了利兹大学成功地从利兹大学脱离了Creavo。

“我认为，Creavo团队开发的技术有可能在急诊医学上产生重大差异，这是紧急未满足临床需求的领域。Creavo有机会成为一家重要的英国医疗设备公司，我期待与史蒂夫和董事会合作，并在这一旅程中合作。”马丁·弗罗斯特（Martin Frost）说。

公司首席执行官史蒂夫·帕克（Steve Parker）补充说：“我很高兴欢迎马丁（Martin）来到克雷沃（Creavo），尤其是在我们迅速发展商业化的时刻。他在成功发展医疗设备业务方面的丰富经验将对公司和我们的股东增值。我要感谢罗伯特对Creavo的承诺以及他的指导和支持，这使我们能够到达今天的位置。”

更多信息在线的：